OrthoPediatrics Corp (KIDS) Stock Analysis
Verdict: HOLD
High gross margins (73.7%) and pediatric niche growth are offset by ongoing net losses, $100M debt, and persistent insider selling.
Investment score: 46/100
Analysis as of
Is OrthoPediatrics Corp stock worth reviewing? AI model thesis
The model score of 46/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 40/100 (weight 15%)
- Technical Momentum: 58/100 (weight 15%)
- Earnings Quality: 42/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 72/100 (weight 10%)
- Risk-Adjusted Return: 42/100 (weight 15%)
OrthoPediatrics Corp opportunities and risks
What speaks for KIDS
- Pediatric Medtech Niche Monopoly
What speaks against KIDS
- Liquidity Squeeze and Capital Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| KIDS | n/a | 2.2x | n/a | 73.7% | -15.7% | -0.3% |
| UFPT | 30.9x | 3.5x | 20.4x | 28.5% | 11.4% | 2.7% |
| STAA | 276.4x | 3.2x | 29.9x | 76.2% | 1.1% | -0.6% |
| BVS | 15.7x | 1.5x | 11.7x | 68.0% | 9.4% | 11.1% |
| CERS | n/a | 2.1x | 177.5x | 52.0% | -3.1% | -0.4% |
| EMBC | 3.9x | 0.3x | 6.0x | 59.9% | 8.6% | 47.8% |
| Peer median | 15.7x | 2.1x | 20.4x | 59.9% | 8.6% | 2.7% |
Frequently asked questions about OrthoPediatrics Corp (KIDS)
Is KIDS stock a good investment?
The cached TradeMates AI model rates OrthoPediatrics Corp as HOLD with an investment score of 46/100. The model score of 46/100 falls in the HOLD range. The central thesis and factor breakdown explain the assessment. This is algorithmic model output, not personal investment advice.
Is KIDS stock a buy?
The TradeMates model verdict for KIDS is HOLD with an investment score of 46/100. Treat this as a model signal to review, not a personal buy recommendation.